EMORY LONG TERM ACUTE CARE — History
CCN 112006 | 3-year financial timeline | COVID resilience: 49/100
🛡️ Public data only — no PHI permitted on this instance.
$27M
Latest Revenue (FY2022)
+2.2%
Revenue CAGR (3yr)
-22.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $26M | $26M | $27M | +1.6% | +2.2% |
| Operating Expenses | $30M | $38M | $33M | -14.0% | +5.0% |
| Operating Margin | -15.9% | -44.8% | -22.6% | +49.7% | +0.0% |
| Net Income | $-4M | $-12M | $-6M | +48.9% | +0.0% |
| Licensed Beds | 50 | 56 | 56 | +0.0% | +5.8% |
| Total Patient Days | 15,735 | 14,607 | 14,263 | -2.4% | -4.8% |
| Medicare Day % | 29% | 29% | 28% | -1.4% | -1.0% |
| Medicaid Day % | 4% | 4% | 8% | +87.2% | +45.3% |
COVID Impact & Recovery
Resilience Score: 49/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +4.4% ($26M → $27M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+2.2%
This Hospital
+7.6%
State Avg
Latest Margin
-22.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $27M | -25.9% |
| FY2024 (proj) | $28M | -29.2% |
| FY2025 (proj) | $29M | -32.5% |